Cargando…
A Network Pharmacology Approach to Explore the Potential Mechanisms of Yifei Sanjie Formula in Treating Pulmonary Fibrosis
OBJECTIVE: Yifei Sanjie Formula (YFSJF) is an effective formula on pulmonary fibrosis (PF), which has been used in clinic for more than 30 years. In order to investigate the molecular mechanism of YFSJF in treating PF, network pharmacology was used to predict the cooperative ingredients and associat...
Autores principales: | Qiao, Bo, Wu, Yueying, Li, Xiaoya, Xu, Zhenyuan, Duan, Weigang, Hu, Yanan, Jia, Wenqing, Fan, Qiuyang, Xing, Haijing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722457/ https://www.ncbi.nlm.nih.gov/pubmed/33335558 http://dx.doi.org/10.1155/2020/8887017 |
Ejemplares similares
-
Yifei Sanjie Formula Treats Chronic Obstructive Pulmonary Disease by Remodeling Pulmonary Microbiota
por: Wu, Yueying, et al.
Publicado: (2022) -
Deciphering the Molecular Mechanism of Yifei-Sanjie Pill in Cancer-Related Fatigue
por: Wu, Yingchao, et al.
Publicado: (2023) -
Network pharmacology and molecular docking to explore the pharmacological mechanism of Yifei Tongluo granules in treating idiopathic pulmonary fibrosis: A review
por: Hou, Yuan, et al.
Publicado: (2023) -
Yifei sanjie Pills Alleviate Chemotherapy-Related Fatigue by Reducing Skeletal Muscle Injury and Inhibiting Tumor Growth in Lung Cancer Mice
por: Wu, Yingchao, et al.
Publicado: (2022) -
Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study
por: Chen, Wenmin, et al.
Publicado: (2023)